9/28/2021NHSA Completes Expert Review of Product Applications for 2021 NRDL

9/28/2021Cyclica and IMPACT Therapeutics Team Up to Advance Differentiated Anti...

9/28/2021I-Mab's Chinese IND Accepted for P2 Trial of Enoblituzumab in Combo wi...

9/27/2021Innovent and UNION Therapeutics Enter License Deal for Next-generation...

9/27/2021Transcenta Cleared for Chinese IND of Anti-sclerostin mAb TST002

9/24/2021Akeso's Chinese NDA for Cadonilimab Accepted by NMPA

9/24/2021Review of Performance Results of Listed Chinese Pharma Companies H1/20...

9/24/2021Review of R&D Investments of Selected Listed Chinese Pharma Companies ...

9/24/2021Snapshot of BMI System Financial Performance in H1/2021

9/24/2021Recent Executive Moves

9/23/2021Sihuan/Xuanzhu and SignalChem Announce Licensing Deal for SLC-391 in G...

9/23/2021Guangzhou Pharma Eyes Public Listing of Subsidiaries

9/23/2021Cytiva Triples Bioprocessing Single-Use Consumables Capacity in China

9/23/2021Innovent's sNDA for Sintilimab in Combo with Chemotherapy as First-L...

9/23/2021Prevalence of Depressive Disorders and Treatment in China: A Cross-Sec...

9/22/2021NMPA Issues Q2/2021 Drug Regulatory Statistics Report

9/22/2021China-based CMS Joins BaseLaunch as Latest Partner

9/17/2021Celsion and Hainan Poly Pharm Sign Agreement to Manufacture Celsion's ...

9/17/2021Recent Executive Moves

9/16/2021Luye Pharma Ties Up with ESTEVE for Its Alzheimer's Patch in Spain

9/16/2021Everest Medicines, Sinovent and SinoMab Enter Licensing Deal for Novel...

9/16/2021AstraZeneca, Daiichi Sankyo Begin New Gastric Cancer Enhertu Trial in ...

9/16/2021Asymchem and LaNova Medicines Form Partnership, Expanding Biological C...

9/16/2021Chinese Pursuit of Avigan Patent Faces Pushback in Japan

9/16/2021Innovent Releases Phase 2 Results of Pemigatinib in Chinese Patients w...

9/15/2021Hua Medicine and Sinopharm Enter Supply Chain Strategic Cooperation

9/15/2021NMPA Holds the 6th China-ASEAN Summit for Drug Development and Coopera...

9/15/2021CStone Secures China NMPA IND Approval for CS2006/NM21-1480

9/15/2021Zai Lab Granted Chinese Breakthrough Therapy Designation for Bemarituz...

9/15/2021BeiGene Announces U.S. FDA Acceptance of BLA for Tislelizumab in ESCC

Page:81/357 Total number of articles:10681: [First][<<] [79] [80] [81] [82] [83] [>>] [End]